(Q37677547)

21 August 2017

1 reference

title

Taming killer cells may halt diabetes progression (English)

1 reference

21 August 2017

1

Francesco Colucci

1 reference

21 August 2017

Corrado M Cilio

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

21 August 2017

1 reference

21 August 2017

volume

11

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

111-112

1 reference

Natural killer cells in human autoimmunity

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

NK cells and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

Human natural killer cell receptors and co-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

NKG2D blockade prevents autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0210-111

The activating receptor NKp46 is essential for the development of type 1 diabetes.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20084067

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NI0210-111

1 reference

21 August 2017

1 reference